| Phytochemical Name : Phenytoin |
| PCNDIDP0089 |
| Pubchem CID : 1775 |
| Molecular formula: C15H12N2O2 |
| Canonical SMILES : C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3 |
Synonymes : phenytoin|5,5-DIPHENYLHYDANTOIN|57-41-0|Diphenylhydantoin|Dilantin|5,5-diphenylimidazolidine-2,4-dione|Phenytoine|Zentropil|Epamin|Lepitoin|Dihydantoin|Aleviatin|Dilabid|Diphantoin|Diphenylan|Diphedan|Fenylepsin|Phentytoin|Sodanton|Difenin|Dihycon|Lehydan|Diphenylhydatanoin|Dantoinal|Di-Hydan|Dilantine|Dillantin|Diphenine|Diphentyn|Ditoinate|Elepsindon|Epilantin|Fenitoina|Fenytoine|Hidantilo|Hidantina|Hidantomin|Hydantoinal|Kessodanten|Phanantin|Phanatine|Phenatoine|Sodantoin|Sylantoic|Thilophenyl|Zentronal|Auranile|Dantinal|Dantoine|Difetoin|Difhydan|Dintoin|Dintoina|Diphedal|Diphenin|Enkelfel|Epifenyl|Epihydan|Fentoin|Hidantal|Hydantal|Idantoil|Idantoin|Labopal|Phentoin|Ritmenal|Saceril|Sanepil|Silantin|Solantin|Danten|Denyl|Epelin|Epinat|Epised|Eptal|Hidan|Lepsin|Oxylan|Ekko|Ictalis simple|Toin unicelles|Dilantin acid|Dantoinal klinos|Om-Hydantoine|Di-Phetine|Epdantoine simple|Hidantina vitoria|Gerot-epilan-D|Epilan-D|Neosidantoina|Comitoina|Hidantina senosian|Hydantol|Minetoin|Novantoina|Causoin|Convul|Di-Lan|Ekko capsules|Neos-Hidantoina|2,4-Imidazolidinedione, 5,5-diphenyl-|Om hidantoina simple|TOIN|Phenhydanin|Phenytex|Phenytoinum|Sinergina|Sodanthon|Iphenylhydantoin|Phenytoin-Gerot|Difenilhidantoina|Fenytoin Dak|Didan TDC 250|Dilantin-125|Epdantoin Simple|Phenytoin AWD|Epilan D|5,5-Diphenyl-2,4-imidazolidinedione|Novophenytoin|Diphenat|Hindatal|Hydantin|Epanutin|Fenitoina [INN-Spanish]|Phenytoine [INN-French]|Phenytoinum [INN-Latin]|Difenilhidantoina [Spanish]|Diphenylhydantoine [French]|Citrulliamon|5,5-Dwufenylohydantoina|Antisacer|Fenitoin|Phenhydan|Phenitoin|Fenantoin Mn Pharma|Fenidantoin s|Diphenylhydantoine|Di-Lan (VAN)|Epasmir 5|PHENYTOIN SODIUM|Diphenylhydantoin (VAN)|Diphentoin|DILANTIN-30|Solantoin|Solantyl|Eptoin|Sodium Diphenylhydantoinate|DPH (VAN)|Fenidantoin 's'|5,5-Diphenylimidazolidin-2,4-dione|5,5-Diphenyl-imidazolidine-2,4-dione|5,5-Diphenylhydantoin (IUPAC)|PHENYTEK|5,5-Dwufenylohydantoina [Polish]|Hydantoin, 5,5-diphenyl-|Epasmir '5'|Didan-tdc-250|CCRIS 515|CHEBI:8107|5,5-diphenyl hydantoin|elepsi ndon|phenat ine|Dihydan toin|fen toin|taco sal|ictalis simp le|NCI-C55765|5,5-Diphenylhydantoin (phenytoin)|phenytoin (PHN)|Dilantin (TN)|component of Mebroin|fenidantoin ''s''|epasmir ''5''|AI3-52498|Phenytoin [USAN:INN:BAN:JAN]|NSC 8722|NSC-8722|EINECS 200-328-6|UNII-6158TKW0C5|MLS000069789|IFLab1_000214|Extended Phenytoin Sodium|DTXSID8020541|5,5-diphenyltetrahydro-1H-2,4-imidazoledione|NSC8722|PHENYTOIN SODIUM, EXTENDED|SM-88 COMPONENT PHENYTOIN|6158TKW0C5|Phenytoin [USAN:USP:INN:BAN:JAN]|HSDB 3160|NCGC00021139-03|SMR000059026|PHENYTOIN (5,5-DIPHENYLHYDANTOIN)|D 4007|5,5-DIPHENYLHYDANTOIN-D5 98 ATOM % D|DTXCID60541|2-hydroxy-5,5-diphenyl-3,5-dihydro-4H-imidazol-4-one|CAS-57-41-0|MFCD00005264|phenytoin-|SR-01000075211|Fenidantoin 's'|Fenidantoin (s)|Epanutin (TN)|Phenytek (TN)|Episar (Salt/Mix)|Eptoin (TN)|Epasmir '5'|Epasmir (5)|Aladdin (Salt/Mix)|Alepsin (Salt/Mix)|Epsolin (Salt/Mix)|Phenytoin (Lepitoin)|Tacosal (Salt/Mix)|Antisacer (Salt/Mix)|Epdantoin (Salt/Mix)|Epileptin (Salt/Mix)|Hydantoin,5-diphenyl-|Spectrum_001105|Fenigramon (Salt/Mix)|Citrullamon (Salt/Mix)|Opera_ID_394|PHENYTOIN [INN]|PHENYTOIN [JAN]|2, 5,5-diphenyl-|PHENYTOIN [MI]|Dilantin Infatabs (TN)|Dilantin Kapseals (TN)|CHEMBL16|PHENYTOIN [HSDB]|PHENYTOIN [IARC]|PHENYTOIN [USAN]|Spectrum2_001281|Spectrum3_000890|Spectrum4_000984|Spectrum5_001369|Lopac-D-4007|PHENYTOIN [VANDF]|D0E4DW|Epitope ID:117723|PHENYTOIN [MART.]|PHENYTOIN [USP-RS]|PHENYTOIN [WHO-DD]|PHENYTOIN [WHO-IP]|SCHEMBL3440|BIDD:PXR0090|Lopac0_000329|Lopac0_000378|Oprea1_373280|BSPBio_001437|Diphenylhydantoin (Phenytoin)|KBioGR_001387|KBioSS_001585|MLS001074087|MLS002454401|BIDD:GT0625|D4007_SIGMA|DivK1c_000507|Soluble phenytoin (Salt/Mix)|SPBio_001281|Phenytoin (JP15/USP/INN)|Phenytoin (JP17/USP/INN)|GTPL2624|PHENYTOIN [ORANGE BOOK]|PHENYTOIN [EP MONOGRAPH]|PHENYTOIN [USP IMPURITY]|KBio1_000507|KBio2_001585|KBio2_004153|KBio2_006721|KBio3_001780|PHENYTOIN [USP MONOGRAPH]|WLN: T5MVMV EHJ ER& ER|5,5-Diphenylhydantoin, >=99%|NINDS_000507|Phenytoin [USAN:BAN:INN:JAN]|Phenytoin 1.0 mg/ml in Methanol|HMS1412J16|HMS1694O05|HMS1791H19|HMS1989H19|HMS2089E11|HMS2236J06|HMS3261K17|HMS3402H19|HMS3657O03|Hydantoin, 5,5-diphenyl-(8CI)|PHENYTOINUM [WHO-IP LATIN]|BCP05960|HY-B0448|Hydantoin, 5,5-diphenyl- (8CI)|Tox21_110861|Tox21_202299|Tox21_300281|Tox21_500378|AC-376|BDBM50003655|BDBM50101816|s2525|STK058029|STK182871|STL454130|AKOS000416887|AKOS003245432|Tox21_110861_1|5,5-diphenylimidazolidine-2,4-dione.|CCG-104011|CCG-221682|CL12003|DB00252|LP00378|Phenytoin 1000 microg/mL in Methanol|2,4-Imidazolidinediona, 5,5-difenil-|5,5-di(phenyl)imidazolidine-2,4-dione|IDI1_000507|IDI1_008433|NCGC00015342-01|NCGC00015342-02|NCGC00015342-03|NCGC00015342-04|NCGC00015342-05|NCGC00015342-06|NCGC00015342-07|NCGC00015342-08|NCGC00015342-09|NCGC00015342-10|NCGC00015342-11|NCGC00015342-12|NCGC00021139-01|NCGC00021139-02|NCGC00021139-04|NCGC00021139-05|NCGC00021139-06|NCGC00021139-07|NCGC00021139-08|NCGC00021139-09|NCGC00021139-10|NCGC00021139-11|NCGC00091492-01|NCGC00091492-02|NCGC00091492-03|NCGC00091492-04|NCGC00091492-05|NCGC00093810-01|NCGC00093810-02|NCGC00254135-01|NCGC00259848-01|NCGC00261063-01|5,5-?Diphenyl-?2,4-?imidazolidinedione|5,5-Diphenyl-1H-imidazolidine-2,4-dione|D0894|EU-0100378|FT-0667653|FT-0699999|P-235|SW203757-2|EN300-16818|2,4-Imidazolidinedione, 5,5-diphenyl-(9CI)|5,5-diphenylimidazolidine-2,4-dione;Phenytoin|C07443|D00512|E76094|2,4-Imidazolidinedione, 5,5-diphenyl- (9CI)|5,5-diphenyl-1H-imidazole-2,4(3H,5H)-dione|AB00374253-10|AB00374253-11|AB00374253_13|A831435|Q410400|SR-01000003141|SR-01000003141-8|SR-01000075211-2|W-105468|BRD-K55930204-001-02-7|BRD-K55930204-236-11-0|Z56786458|4-hydroxy-5,5-diphenyl-1,5-dihydro-2H-imidazol-2-one|F0020-1370|Phenytoin, European Pharmacopoeia (EP) Reference Standard|Phenytoin, United States Pharmacopeia (USP) Reference Standard|Phenytoin, Pharmaceutical Secondary Standard; Certified Reference Material|Phenytoin for system suitability, European Pharmacopoeia (EP) Reference Standard |
| Structure | |
| 3D structure | 2D structure |
![]() |
| Log Po/w (iLOGP) : 1.650 |
| Log Po/w (XLOGP3) : 2.470 |
| Log Po/w (WLOGP) : 0.900 |
| Log Po/w (MLOGP) : 2.010 |
| Log Po/w (SILICOS-IT) : 2.420 |
| Consensus Log Po/w : 1.890 |

